2 active warrant series covering 15,870,072 shares (~26% potential dilution); nearest expiry 2028-04-29.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| finder | $0.20 | Apr 29, 2028 577d | 447K | OTM | 0.7% | C$89K | Auto |
| warrant | $0.30 | Apr 29, 2028 577d | 15.4M | OTM | 25.3% | C$4.6M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
1 option grant covering 611,871 shares (~1% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.10 | Oct 14, 2027 379d | 612K | ITM | 1.0% | C$61K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
60,925,605 shares outstanding, plus 15,870,072 from warrants and 611,871 from options — a fully diluted 77,407,548 shares, or ~27.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
2 active warrant series covering 15,870,072 shares (~26% potential dilution); nearest expiry 2028-04-29.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| finder | $0.20 | Apr 29, 2028 577d | 447K | OTM | 0.7% | C$89K | Auto |
| warrant | $0.30 | Apr 29, 2028 577d | 15.4M | OTM | 25.3% | C$4.6M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
1 option grant covering 611,871 shares (~1% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.10 | Oct 14, 2027 379d | 612K | ITM | 1.0% | C$61K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
60,925,605 shares outstanding, plus 15,870,072 from warrants and 611,871 from options — a fully diluted 77,407,548 shares, or ~27.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
